News Detail
New Delhi, 27 April 2023: Maintaining the standard of made-in-India medicines is of ‘paramount importance’, the country’s apex drug regulator has told states and Union Territories amid fixing quality issues of the Indian pharmaceutical industry.
The m......
View Details
Source : News 18
active pharmaceutical ingredients
DCGI
paracetamol
Ministry of Health and Family Welfare
uzbekistan
Gambia
United states
DCGI Rajeev Singh Raghuvanshi
Indian pharmaceutical industry
Related News
- Supplying fake medicines for eight months, four arrested (25-09-2023)
- Firozpur STF arrested drug smuggler with 1100 intoxicating pills (25-09-2023)
- Varanasi, 84 stockists did business worth crores by creating dummy firms (25-09-2023)
- Gujarat FDCA attributes 45% of drug samples failing quality tests due to dissolution testing (25-09-2023)
- CDSCO says samples labelled as Cipla's and Sun Pharma's drugs failed in July could be spurious (25-09-2023)
- Govt in process of identifying additional regulatory interventions to stop Misuse of Antimicrobials (25-09-2023)
- Resistance to last-resort antibiotics Carbapenem growing in India: ICMR report (25-09-2023)
- 4 arrested with 375 bottles of Eskuf cough syrup worth Rs 4 lakh (25-09-2023)
- Ghaziabad: Fake Augmentin 625 Duo and Ultracet worth Rs 8 lakh seized, four arrested (24-09-2023)
- Police recovered 292 intoxicating capsules and 5760 pills in Ambala (24-09-2023)